These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 12050211)
1. Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19). Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Kasai T; Inoue M J Clin Endocrinol Metab; 2002 Jun; 87(6):2540-8. PubMed ID: 12050211 [TBL] [Abstract][Full Text] [Related]
2. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. Bulun SE; Simpson ER; Word RA J Clin Endocrinol Metab; 1994 Mar; 78(3):736-43. PubMed ID: 8126151 [TBL] [Abstract][Full Text] [Related]
3. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826 [TBL] [Abstract][Full Text] [Related]
4. Spatially heterogeneous expression of aromatase P450 through promoter II is closely correlated with the level of steroidogenic factor-1 transcript in endometrioma tissues. Yang HJ; Shozu M; Murakami K; Sumitani H; Segawa T; Kasai T; Inoue M J Clin Endocrinol Metab; 2002 Aug; 87(8):3745-53. PubMed ID: 12161505 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes. Zhao Y; Mendelson CR; Simpson ER Mol Endocrinol; 1995 Mar; 9(3):340-9. PubMed ID: 7776980 [TBL] [Abstract][Full Text] [Related]
6. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism. Sumitani H; Shozu M; Segawa T; Murakami K; Yang HJ; Shimada K; Inoue M Endocrinology; 2000 Oct; 141(10):3852-61. PubMed ID: 11014242 [TBL] [Abstract][Full Text] [Related]
7. Functional analysis of the I.3, I.6, pII and I.4 promoters of CYP19 (aromatase) gene in human osteoblasts and their role in vitamin D and dexamethasone stimulation. Enjuanes A; Garcia-Giralt N; Supervía A; Nogués X; Ruiz-Gaspà S; Bustamante M; Mellibovsky L; Grinberg D; Balcells S; Díez-Pérez A Eur J Endocrinol; 2005 Dec; 153(6):981-8. PubMed ID: 16322405 [TBL] [Abstract][Full Text] [Related]
8. Estrogen biosynthesis in THP1 cells is regulated by promoter switching of the aromatase (CYP19) gene. Shozu M; Zhao Y; Simpson ER Endocrinology; 1997 Dec; 138(12):5125-35. PubMed ID: 9389492 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate. Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Inoue M J Clin Endocrinol Metab; 2001 Nov; 86(11):5405-11. PubMed ID: 11701714 [TBL] [Abstract][Full Text] [Related]
10. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. Agarwal VR; Ashanullah CI; Simpson ER; Bulun SE J Clin Endocrinol Metab; 1997 Jan; 82(1):70-4. PubMed ID: 8989235 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Zeitoun K; Takayama K; Michael MD; Bulun SE Mol Endocrinol; 1999 Feb; 13(2):239-53. PubMed ID: 9973254 [TBL] [Abstract][Full Text] [Related]
13. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6. Shozu M; Zhao Y; Bulun SE; Simpson ER Endocrinology; 1998 Apr; 139(4):1610-7. PubMed ID: 9528941 [TBL] [Abstract][Full Text] [Related]
14. Aromatase expression in uterine leiomyomata is regulated primarily by proximal promoters I.3/II. Imir AG; Lin Z; Yin P; Deb S; Yilmaz B; Cetin M; Cetin A; Bulun SE J Clin Endocrinol Metab; 2007 May; 92(5):1979-82. PubMed ID: 17341559 [TBL] [Abstract][Full Text] [Related]
15. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase. Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385 [TBL] [Abstract][Full Text] [Related]
16. CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. Bulun SE; Economos K; Miller D; Simpson ER J Clin Endocrinol Metab; 1994 Dec; 79(6):1831-4. PubMed ID: 7989490 [TBL] [Abstract][Full Text] [Related]
17. Different promoter usage for CYP19 gene expression in buffalo ovary and placenta. Sharma D; Ghai S; Singh D Gen Comp Endocrinol; 2009 Jul; 162(3):319-28. PubMed ID: 19375426 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Zhao Y; Nichols JE; Valdez R; Mendelson CR; Simpson ER Mol Endocrinol; 1996 Nov; 10(11):1350-7. PubMed ID: 8923461 [TBL] [Abstract][Full Text] [Related]
19. Regulation of aromatase gene expression in purified germ cells of adult male rats: effects of transforming growth factor beta, tumor necrosis factor alpha, and cyclic adenosine 3',5'-monosphosphate. Bourguiba S; Chater S; Delalande C; Benahmed M; Carreau S Biol Reprod; 2003 Aug; 69(2):592-601. PubMed ID: 12700195 [TBL] [Abstract][Full Text] [Related]
20. Promoter activity and chromosomal location of the Rana rugosa P450 aromatase (CYP19) gene. Oshima Y; Kato T; Wang D; Murakami T; Matsuda Y; Nagahama Y; Nakamura M Zoolog Sci; 2006 Jan; 23(1):79-85. PubMed ID: 16547409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]